Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Patent
1990-12-24
1992-03-10
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
514974, 514849, 514888, 514 58, 514777, 424464, 424 58, 424439, 424440, 424441, 424442, 424489, 424641, 424643, A61K 910, A61K 968
Patent
active
050950355
ABSTRACT:
Thermally, chemically and flavor stable compositions for oral absorption by a human containing zinc acetate with a consumable, sweet pharmaceutical carrier and prepared in the form of a pleasant testing lozenge, powder, liquid or chewable composition for delivery of zinc to the oral and oral pharyngeal mucosa of a human with said composition being absent the normal offensive aftertaste of zinc, and being primarily intended for use in treating common colds or in nutritional supplementation.
REFERENCES:
patent: Re33465 (1990-11-01), Eby
patent: 153421 (1874-07-01), Butts
patent: 2648609 (1953-08-01), Wurster
patent: 4503070 (1985-03-01), Eby
patent: 4684528 (1987-08-01), Godfrey
patent: 4764375 (1988-08-01), Paradissis
patent: 4766004 (1988-08-01), Moskowitz
patent: 4777162 (1988-10-01), Hijiya et al.
patent: 4794014 (1988-12-01), Siren
patent: 4956385 (1990-09-01), Eby, III
patent: 4980169 (1990-12-01), Oppenheimer et al.
patent: 5002970 (1991-03-01), Eby, III
Failure of Zinc Acetate Lozenges to Alter the Course of Upper Respiratory Tract Infections in Australian Adults, by Douglas et al., Antimicrobial Agents and Chemotherapy, Aug. 1987, p. 1263.
Personal letter from R. M. Douglas to G. Eby dated Sep. 3, 87.
Personal letter from R. J. E. Williams to R. M. Douglas, Aug. 27, 87.
Reduction in Duration of Common Colds by Zinc Gluconate Lozenges . . . Eby et al., Aptimicrobial Agents and Chemotherapy, vol. 25, pp. 20-24, 1984.
Prophylaxis and Treatment of Rhinovirus Colds with zinc gluconate lozenges, by W. A. Nakib et al., Journal of Antimicrobial Chemotherapy, vol. 20, pp. 893-901, 1987.
Zinc and the Common Cold: Positive Findings in a Controlled Clinical Study Using a new Formulation by J. C. Godfrey et al. in 1991.
Two Randomized Controlled Trials of Zinc Gluconate Lozenge Therapy of Experimentally Induced Rhinovirus Colds by B. M. Farr in Antimicrobial Agents and Chemotherapy, 1987 vol. 131, p. 1183.
LandOfFree
Flavor stable zinc acetate compositions for oral absorption does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Flavor stable zinc acetate compositions for oral absorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flavor stable zinc acetate compositions for oral absorption will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2284788